The Trump administration has initiated a sweeping overhaul of American scientific research with the launch of the five-billion-dollar Genesis Mission grants and the release of White House science adviser Michael Kratsios’ Golden Age of American Science manifesto. Unveiled on Capitol Hill and coordinated through the Department of Energy, the initiative directs federal funding toward hundreds of artificial intelligence-driven projects spanning energy, robotics, advanced materials, and biomedical research. Major technology firms, including Google, Microsoft, and OpenAI, are contributing substantial computing resources to support the effort. The policy establishes a decisive pivot from traditional institutional funding toward individual researchers, private-sector partnerships, and politically guided allocations. Kratsios framed the agenda as a modern successor to Vannevar Bush’s 1945 science policy framework, yet the manifesto fundamentally restructures federal support by prioritizing measurable outcomes, accelerating grant cycles, and granting political appointees expanded authority to block grants. The strategy explicitly favors goal-oriented research that mirrors venture capital methodologies, emphasizing rapid iteration and clear performance targets over open-ended exploration. Academic experts and research leaders have strongly criticized the proposal, warning that the administration’s startup-centric model misunderstands the fundamental mechanics of scientific discovery. Scholars emphasize that basic research requires long-term funding and institutional stability, as breakthroughs frequently emerge from serendipitous inquiry rather than predetermined commercial objectives. Critics also point to internal contradictions within the agenda, particularly its simultaneous recommendation to curtail life sciences funding while expanding biological research, alongside an overreliance on artificial intelligence that experts describe as currently generating unreliable outputs without rigorous human oversight. The funding realignment arrives amid broader federal budget reductions and grant cancellations that have already disrupted university programs and national laboratories. Researchers argue that dismantling established academic ecosystems to favor tech-sector innovation will likely erode the United States’ long-term competitive edge in fundamental science. While the administration characterizes the reforms as necessary steps to eliminate bureaucratic inefficiencies and modernize research, many scientists view the strategy as a politicized restructuring that privileges immediate commercial returns and ideological alignment. The transition may yield short-term advantages for venture capital and technology companies, but experts caution that it risks inflicting lasting damage on the foundational institutions that have historically sustained American scientific leadership.